Notice of Intent To Establish the Pain Management Best Practices Inter-Agency Task Force and Request for Nominations for Task Force Members, 40772-40774 [2017-18182]
Download as PDF
<![CDATA[
40772
Federal Register / Vol. 82, No. 165 / Monday, August 28, 2017 / Notices
Therefore, you should always check the
Agency’s Web site at https://
www.fda.gov/AdvisoryCommittees/
default.htm and scroll down to the
appropriate advisory committee meeting
link, or call the advisory committee
information line to learn about possible
modifications before coming to the
meeting.
asabaliauskas on DSKBBXCHB2PROD with NOTICES
SUPPLEMENTARY INFORMATION:
Agenda: The committee will discuss
appropriate patient selection criteria
and clinical trial design features,
including acceptable endpoints, for
demonstrating clinical benefit for drugs
intended to treat interstitial cystitis and
bladder pain syndrome. The committee
will also discuss whether bladder pain
syndrome and interstitial cystitis reflect
overlapping or different populations,
and whether it is appropriate to assess
efficacy in the same way for both
conditions.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee meeting
link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. All electronic and
written submissions submitted to the
docket (see ADDRESSES) on or before
November 22, 2017, will be provided to
the committee. Oral presentations from
the public will be scheduled between
approximately 1 p.m. and 2 p.m. Those
individuals interested in making formal
oral presentations should notify the
contact person and submit a brief
statement of the general nature of the
evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before November 14, 2017. Time
allotted for each presentation may be
limited. If the number of registrants
requesting to speak is greater than can
be reasonably accommodated during the
scheduled open public hearing session,
FDA may conduct a lottery to determine
the speakers for the scheduled open
public hearing session. The contact
person will notify interested persons
VerDate Sep<11>2014
18:45 Aug 25, 2017
Jkt 241001
regarding their request to speak by
November 15, 2017.
Persons attending FDA’s advisory
committee meetings are advised that the
Agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with disabilities.
If you require special accommodations
due to a disability, please contact
Kalyani Bhatt at least 7 days in advance
of the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: August 22, 2017.
Anna K. Abram,
Deputy Commissioner for Policy, Planning,
Legislation, and Analysis.
[FR Doc. 2017–18131 Filed 8–25–17; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meeting of the National Advisory
Committee on Rural Health and Human
Services
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice of Meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, notice
is hereby given of a National Advisory
Committee on Rural Health and Human
Services (NACRHHS) meeting. The
meeting will be open to the public.
Informaton about the NACRHHS
meeting can be obtained by accessing
the following Web site: https://
www.hrsa.gov/advisorycommittees/
rural/.
DATES: The meeting will be held on
September 11, 2017, 8:45 a.m. to 5:00
p.m. MDT; September 12, 2017, 8:30
a.m. to 5:15 p.m. MDT; and September
13, 2017, 8:30 a.m. to 11:00 a.m. MDT.
ADDRESSES: This meeting will be held at
the Spring Hill Suites located at 424 E.
Parkcenter Blvd., Boise, Idaho 83706,
(208) 342–1044.
SUMMARY:
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
FOR FURTHER INFORMATION CONTACT:
Steve Hirsch, MSLS, Administrative
Coordinator, National Advisory
Committee on Rural Health and Human
Services, Health Resources and Services
Administration, Parklawn Building,
17W29C, 5600 Fishers Lane, Rockville,
MD 20857, Telephone (301) 443–0835,
Fax (301) 443–2803.
SUPPLEMENTARY INFORMATION:
NACRHHS provides counsel and
recommendations to the Secretary with
respect to the delivery, research,
development, and administration of
health and human services in rural
areas.
The meeting on Monday, September
11, will be called to order at 8:45 a.m.
by the Chairperson of the Committee,
The Honorable Ronnie Musgrove. The
Committee will examine the issue of
suicide in rural areas and the issue of
Rural Health Clinic Modernization. The
day will conclude with a period of
public comment at approximately 5:15
p.m.
The Committee will break into
Subcommittees and depart for site visits
Tuesday morning, September 12, at
approximately 8:15 a.m. Subcommittees
will visit First Baptist Church, 126 S.
Hayes Avenue in Emmett, Idaho and the
North Canyon Medical Center, 267 N.
Canyon Drive in Gooding, Idaho. The
day will conclude at the Spring Hill
Suites with a period of public comment
at approximately 5:00 p.m.
The Committee will meet to
summarize key findings and develop a
work plan for the next quarter and the
following meeting on Wednesday
morning, September 13, at 8:30 a.m.
Persons interested in attending any
portion of the meeting should contact
Alfred Delena at the Federal Office of
Rural Health Policy (FORHP) via
telephone at (301) 443–3388 or by email
at ADelena@hrsa.gov. The Committee
meeting agenda will be posted on the
Committee’s Web site at https://
www.hrsa.gov/advisorycommittees/
rural/.
Amy McNulty,
Acting Director, Division of the Executive
Secretariat.
[FR Doc. 2017–18139 Filed 8–25–17; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Notice of Intent To Establish the Pain
Management Best Practices InterAgency Task Force and Request for
Nominations for Task Force Members
Office of the Assistant
Secretary for Health, Office of the
AGENCY:
E:\FR\FM\28AUN1.SGM
28AUN1
Federal Register / Vol. 82, No. 165 / Monday, August 28, 2017 / Notices
Secretary, U.S. Department of Health
and Human Services.
ACTION: Notice.
The U.S. Department of
Health and Human Services (HHS)
hereby gives notice of its intent to
establish the Pain Management Best
Practices Inter-Agency Task Force (Task
Force) pursuant to section 101 of the
Comprehensive Addiction and Recovery
Act of 2016. The Task Force will consist
of representatives of specific Federal
agencies and non-federal individuals
and entities who represent diverse
disciplines and views. The Task Force
will provide advice and
recommendations for development of
best practices for pain management and
prescribing pain medication and a
strategy for disseminating such best
practices to relevant Federal agencies
and the general public.
Through this notice, HHS is also
requesting nominations of individuals
who are interested in being considered
for appointment to the Task Force.
Resumes or curricula vitae from
qualified individuals who wish to be
considered for appointment as a
member of the Task Force are currently
being accepted.
DATES: Nominations must be received
no later than close of business
September 27, 2017.
ADDRESSES: All nominations must be
submitted via email to the attention of
Vanila M. Singh, M.D., Chief Medical
Officer at PainTaskforce@hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Vanila M. Singh, M.D., Chief Medical
Officer, Office of the Assistant Secretary
for Health; U.S. Department of Health
and Human Services; Telephone: (202)
205–3841; Fax: (202) 205–2107; Email
address: PainTaskforce@hhs.gov. When
the charter for the Task Force has been
filed with the appropriate Congressional
committees and the Library of Congress,
this document will be made available
online. Web site information about
activities of the Task Force will be
provided when the URL has been
identified. The charter will include
detailed information about the purpose,
function, and structure of the Task
Force.
SUPPLEMENTARY INFORMATION: Section
101 of the Comprehensive Addiction
and Recovery Act of 2016 (Pub. L. 114–
198) (CARA) authorizes the Secretary of
HHS, in cooperation with the Secretary
of Veterans Affairs and the Secretary of
Defense, to convene the Task Force. The
Task Force will consist of
representatives of specific Federal
agencies and non-federal individuals
and entities who represent diverse
asabaliauskas on DSKBBXCHB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:45 Aug 25, 2017
Jkt 241001
disciplines and views. The Task Force
will identify, review, and determine
whether there are gaps or
inconsistencies in best practices among
Federal agencies; propose updates to
best practices and recommendations on
addressing gaps or inconsistencies;
provide the public with an opportunity
to comment on any proposed updates
and recommendations; and develop a
strategy for disseminating information
about best practices.
The Task Force will provide advice
and recommendations for development
of best practices for pain management
and prescribing pain medication and a
strategy for disseminating such best
practices to relevant Federal agencies
and the general public. The functions of
the Task Force will be solely advisory
in nature. The Task Force will be
established as a non-discretionary
Federal advisory committee.
When the charter for the Task Force
is approved, it will be filed with the
appropriate Congressional committees
and the Library of Congress; hard copies
of this document will be made available
upon request. The approved charter will
also be accessible online.
Objectives and Scope of Activities.
The Secretary of HHS, in cooperation
with the Secretary of Veterans Affairs
and the Secretary of Defense, shall
convene the Task Force to identify,
review, and determine whether there are
gaps or inconsistencies in best practices
among Federal agencies; propose
updates to best practices and
recommendations on addressing gaps or
inconsistencies; provide the public with
an opportunity to comment on any
proposed updates and
recommendations; and develop a
strategy for disseminating information
about best practices.
Membership and Designation. The
Task Force shall consist of not more
than 30 members. The Assistant
Secretary for Health of HHS shall select
the Chair. The Chair may select a Vicechair from among Task Force members.
The members of the Task Force shall
include currently licensed and
practicing physicians, dentists, and nonphysician prescribers; currently
licensed and practicing pharmacists and
pharmacies; experts in the fields of pain
research and addiction research,
including adolescent and young adult
addiction; experts on the health of, and
prescription opioid use disorders in,
members of the Armed Forces and
veterans; and experts in the field of
minority health. The members of the
Task Force shall also include
individuals who are appointed to serve
under CARA subsection 101(c)(5) as
representatives of pain management
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
40773
professional organizations; the mental
health treatment community; the
addiction treatment community,
including individuals in recovery from
substance use disorder; pain advocacy
groups, including patients; veteran
service organizations; groups with
expertise on overdose reversal,
including first responders; State medical
boards; and hospitals. The Secretary
shall ensure that the membership of the
Task Force includes individuals who
represent rural and underserved areas.
The composition of the Task Force shall
also include federal members who shall
serve as representatives for the
following departments and agency: The
Department of Health and Human
Services and relevant HHS agencies, the
Department of Veterans Affairs, the
Department of Defense, and the Office of
National Drug Control Policy.
Members who are not officers or
employees of the United States
Government and who are not appointed
as representative members under CARA
subsection 101(c)(5) shall be classified
as special government employees
(SGEs). Members of the Task Force who
are officers or employees of the United
States Government shall be appointed to
serve at the discretion of the head of the
respective Federal departments and
agency. All members shall be appointed
to serve for the duration of time that the
Task Force is authorized to operate. Any
member who is appointed to fill the
vacancy of an unexpired term shall be
appointed to serve for the remainder of
that term.
Pursuant to advance written
agreement, members of the Task Force
who are not officers or employees of the
United States Government shall receive
no stipend for the advisory service that
they render as members of the Task
Force. Members appointed as SGEs shall
receive per diem and reimbursement for
travel expenses incurred in relation to
performing duties for the Task Force, as
authorized by law under 5 U.S.C. 5703
for persons who are employed
intermittently to perform services for
the Federal government and in
accordance with Federal travel
regulations. Members appointed as
representatives of a designated entity
under CARA subsection 101(c)(5) may
be allowed to receive per diem and
reimbursement for any applicable
expenses that are incurred to conduct
business related to the Task Force.
Federal employees assigned as advisory
committee members or staff members
remain covered under their current
compensation system.
Estimated Number and Frequency of
Meetings. The Task Force shall meet not
less than two times a calendar year,
E:\FR\FM\28AUN1.SGM
28AUN1
asabaliauskas on DSKBBXCHB2PROD with NOTICES
40774
Federal Register / Vol. 82, No. 165 / Monday, August 28, 2017 / Notices
depending upon the availability of
funds. The meetings may be conducted
by teleconference or videoconference at
the discretion of the Designated Federal
Officer. The meetings shall be open to
the public, except as determined
otherwise by the Secretary, or other
official to whom authority has been
delegated, in accordance with the
guidelines under Government in the
Sunshine Act, 5 U.S.C. 552b(c). Notice
of all meetings shall be provided to the
public in accordance with the Federal
Advisory Committee Act. Meetings shall
be conducted and records of the
proceedings shall be kept, as required
by applicable laws and departmental
policies. A quorum is required for the
Task Force to meet to conduct business.
A quorum shall consist of a majority of
the Task Force’s members. When the
Secretary or the Secretary’s designee
determines that a meeting shall be
closed or partially closed to the public,
in accordance with provisions of
Government in the Sunshine Act, 5
U.S.C. 552b(c), then a report shall be
prepared by the Designated Federal
Officer that includes, at a minimum, a
list of members and their business
addresses, the Task Force’s functions,
date and place of the meeting, and a
summary of the Task Force’s activities
and recommendations made during the
fiscal year. A copy of the report shall be
provided to the Department Committee
Management Officer.
Nominations: Nominations, including
self-nominations, of individuals who
have the specified expertise and
knowledge will be considered for
appointment as members of the Task
Force. A nomination should include, at
a minimum, the following for each
nominee: (1) A letter of nomination that
clearly states the name and affiliation of
the nominee, the basis for the
nomination, and a statement from the
nominee that indicates that the
individual is willing to serve as a
member of the Task Force, if selected;
(2) the nominator’s name, address, and
daytime telephone number, and the
address, telephone number, and email
address of the individual being
nominated; and (3) a current copy of the
nominee’s curriculum vitae or resume,
which should be limited to no more
than 10 pages.
Every effort will be made to ensure
that the composition of the Task Force
includes individuals from various
geographic locations, including rural
and underserved areas; racial and ethnic
minorities; genders, and persons living
with disabilities.
Individuals other than officers or
employees of the United States
government being considered for
VerDate Sep<11>2014
18:45 Aug 25, 2017
Jkt 241001
appointment as members of the Task
Force will be required to complete and
submit a report of their financial
holdings. An ethics review must be
conducted to ensure that individuals
appointed as members of the Task Force
are not involved in any activity that may
pose a potential conflict of interest for
the official duties that are to be
performed. This is a federal ethics
requirement that must be satisfied upon
entering the position and annually
throughout the established term of
appointment on the Task Force.
Authority: Section 101 of the
Comprehensive Addiction and Recovery
Act of 2016 (Pub. L. 114–198) authorizes
establishment of the Pain Management
Best Practices Inter-Agency Task Force.
The Task Force will be governed by
provisions of the Federal Advisory
Committee Act, Public Law 92–463, as
amended (5 U.S.C. App. 2), which sets
forth standards for the formation and
use of Federal advisory committees.
Dated: August 21, 2017.
Donald Wright,
Acting Assistant Secretary for Health.
[FR Doc. 2017–18182 Filed 8–25–17; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Document Identifier: OS–0990–new]
Agency Information Collection
Request. 30-Day Public Comment
Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before September 27,
2017.
SUMMARY:
Submit your comments to
OIRA_submission@omb.eop.gov or via
facsimile to (202) 395–5806.
FOR FURTHER INFORMATION CONTACT:
Sherrette Funn, Sherrette.Funn@hhs.gov
or (202) 795–7714. When submitting
comments or requesting information,
please include the document identifier
0990-New-30D and project title for
reference
ADDRESSES:
Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Project Title: Assessment of the
Impact of Energy Development on the
Behavioral Health of Women in Western
North Dakota and Eastern Montana, The
Region VIII Office of the Assistant
Secretary for Health (OASH), Office on
Women’s Health (OWH).
Abstract: The Office on Women’s
Health (OWH) in the Office of the
Assistant Secretary for Health, U.S.
Department of Health and Human
Services (HHS) is requesting approval
from the Office of Management and
Budget (OMB) for a new data collection
for the Assessment of the Impact of
Energy Development on the Behavioral
Health of Women in Western North
Dakota and Eastern Montana. Its
mission is to provide national
leadership and coordination to improve
the health of women and girls through
policy, education and model programs.
Region VIII OASH/OWH is interested in
improving women’s behavioral health
associated with the impact of energy
development through gender based data
collection and analysis. The discovery
and subsequent development of the
Parshall Oil Field within the Bakken
region of Western North Dakota has led
to significant economic opportunity and
population growth in the region (Eastern
Montana and Western North Dakota).
Rapid population growth has many
intended and unintended consequences,
both positive and negative, on the social
and economic environment of the region
and, consequently, the population’s
health and well-being.
Need and Proposed Use of the
Information: There are welldocumented environmental health
issues associated with oil and gas
development, including air, water, soil,
noise, and light pollution. However,
there are additional social, physical and
mental health effects that are less well
documented. Current research is very
limited, but preliminary evidence
suggests that women have unmet
behavioral health needs due in part to
the energy development and population
surge in region. These data will
ultimately be used to understand the
impact of energy development on the
behavioral health of women in Eastern
Montana and Western North Dakota.
E:\FR\FM\28AUN1.SGM
28AUN1
]]>Agencies
[Federal Register Volume 82, Number 165 (Monday, August 28, 2017)]
[Notices]
[Pages 40772-40774]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18182]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Notice of Intent To Establish the Pain Management Best Practices
Inter-Agency Task Force and Request for Nominations for Task Force
Members
AGENCY: Office of the Assistant Secretary for Health, Office of the
[[Page 40773]]
Secretary, U.S. Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The U.S. Department of Health and Human Services (HHS) hereby
gives notice of its intent to establish the Pain Management Best
Practices Inter-Agency Task Force (Task Force) pursuant to section 101
of the Comprehensive Addiction and Recovery Act of 2016. The Task Force
will consist of representatives of specific Federal agencies and non-
federal individuals and entities who represent diverse disciplines and
views. The Task Force will provide advice and recommendations for
development of best practices for pain management and prescribing pain
medication and a strategy for disseminating such best practices to
relevant Federal agencies and the general public.
Through this notice, HHS is also requesting nominations of
individuals who are interested in being considered for appointment to
the Task Force. Resumes or curricula vitae from qualified individuals
who wish to be considered for appointment as a member of the Task Force
are currently being accepted.
DATES: Nominations must be received no later than close of business
September 27, 2017.
ADDRESSES: All nominations must be submitted via email to the attention
of Vanila M. Singh, M.D., Chief Medical Officer at
PainTaskforce@hhs.gov.
FOR FURTHER INFORMATION CONTACT: Vanila M. Singh, M.D., Chief Medical
Officer, Office of the Assistant Secretary for Health; U.S. Department
of Health and Human Services; Telephone: (202) 205-3841; Fax: (202)
205-2107; Email address: PainTaskforce@hhs.gov. When the charter for
the Task Force has been filed with the appropriate Congressional
committees and the Library of Congress, this document will be made
available online. Web site information about activities of the Task
Force will be provided when the URL has been identified. The charter
will include detailed information about the purpose, function, and
structure of the Task Force.
SUPPLEMENTARY INFORMATION: Section 101 of the Comprehensive Addiction
and Recovery Act of 2016 (Pub. L. 114-198) (CARA) authorizes the
Secretary of HHS, in cooperation with the Secretary of Veterans Affairs
and the Secretary of Defense, to convene the Task Force. The Task Force
will consist of representatives of specific Federal agencies and non-
federal individuals and entities who represent diverse disciplines and
views. The Task Force will identify, review, and determine whether
there are gaps or inconsistencies in best practices among Federal
agencies; propose updates to best practices and recommendations on
addressing gaps or inconsistencies; provide the public with an
opportunity to comment on any proposed updates and recommendations; and
develop a strategy for disseminating information about best practices.
The Task Force will provide advice and recommendations for
development of best practices for pain management and prescribing pain
medication and a strategy for disseminating such best practices to
relevant Federal agencies and the general public. The functions of the
Task Force will be solely advisory in nature. The Task Force will be
established as a non-discretionary Federal advisory committee.
When the charter for the Task Force is approved, it will be filed
with the appropriate Congressional committees and the Library of
Congress; hard copies of this document will be made available upon
request. The approved charter will also be accessible online.
Objectives and Scope of Activities. The Secretary of HHS, in
cooperation with the Secretary of Veterans Affairs and the Secretary of
Defense, shall convene the Task Force to identify, review, and
determine whether there are gaps or inconsistencies in best practices
among Federal agencies; propose updates to best practices and
recommendations on addressing gaps or inconsistencies; provide the
public with an opportunity to comment on any proposed updates and
recommendations; and develop a strategy for disseminating information
about best practices.
Membership and Designation. The Task Force shall consist of not
more than 30 members. The Assistant Secretary for Health of HHS shall
select the Chair. The Chair may select a Vice-chair from among Task
Force members. The members of the Task Force shall include currently
licensed and practicing physicians, dentists, and non-physician
prescribers; currently licensed and practicing pharmacists and
pharmacies; experts in the fields of pain research and addiction
research, including adolescent and young adult addiction; experts on
the health of, and prescription opioid use disorders in, members of the
Armed Forces and veterans; and experts in the field of minority health.
The members of the Task Force shall also include individuals who are
appointed to serve under CARA subsection 101(c)(5) as representatives
of pain management professional organizations; the mental health
treatment community; the addiction treatment community, including
individuals in recovery from substance use disorder; pain advocacy
groups, including patients; veteran service organizations; groups with
expertise on overdose reversal, including first responders; State
medical boards; and hospitals. The Secretary shall ensure that the
membership of the Task Force includes individuals who represent rural
and underserved areas. The composition of the Task Force shall also
include federal members who shall serve as representatives for the
following departments and agency: The Department of Health and Human
Services and relevant HHS agencies, the Department of Veterans Affairs,
the Department of Defense, and the Office of National Drug Control
Policy.
Members who are not officers or employees of the United States
Government and who are not appointed as representative members under
CARA subsection 101(c)(5) shall be classified as special government
employees (SGEs). Members of the Task Force who are officers or
employees of the United States Government shall be appointed to serve
at the discretion of the head of the respective Federal departments and
agency. All members shall be appointed to serve for the duration of
time that the Task Force is authorized to operate. Any member who is
appointed to fill the vacancy of an unexpired term shall be appointed
to serve for the remainder of that term.
Pursuant to advance written agreement, members of the Task Force
who are not officers or employees of the United States Government shall
receive no stipend for the advisory service that they render as members
of the Task Force. Members appointed as SGEs shall receive per diem and
reimbursement for travel expenses incurred in relation to performing
duties for the Task Force, as authorized by law under 5 U.S.C. 5703 for
persons who are employed intermittently to perform services for the
Federal government and in accordance with Federal travel regulations.
Members appointed as representatives of a designated entity under CARA
subsection 101(c)(5) may be allowed to receive per diem and
reimbursement for any applicable expenses that are incurred to conduct
business related to the Task Force. Federal employees assigned as
advisory committee members or staff members remain covered under their
current compensation system.
Estimated Number and Frequency of Meetings. The Task Force shall
meet not less than two times a calendar year,
[[Page 40774]]
depending upon the availability of funds. The meetings may be conducted
by teleconference or videoconference at the discretion of the
Designated Federal Officer. The meetings shall be open to the public,
except as determined otherwise by the Secretary, or other official to
whom authority has been delegated, in accordance with the guidelines
under Government in the Sunshine Act, 5 U.S.C. 552b(c). Notice of all
meetings shall be provided to the public in accordance with the Federal
Advisory Committee Act. Meetings shall be conducted and records of the
proceedings shall be kept, as required by applicable laws and
departmental policies. A quorum is required for the Task Force to meet
to conduct business. A quorum shall consist of a majority of the Task
Force's members. When the Secretary or the Secretary's designee
determines that a meeting shall be closed or partially closed to the
public, in accordance with provisions of Government in the Sunshine
Act, 5 U.S.C. 552b(c), then a report shall be prepared by the
Designated Federal Officer that includes, at a minimum, a list of
members and their business addresses, the Task Force's functions, date
and place of the meeting, and a summary of the Task Force's activities
and recommendations made during the fiscal year. A copy of the report
shall be provided to the Department Committee Management Officer.
Nominations: Nominations, including self-nominations, of
individuals who have the specified expertise and knowledge will be
considered for appointment as members of the Task Force. A nomination
should include, at a minimum, the following for each nominee: (1) A
letter of nomination that clearly states the name and affiliation of
the nominee, the basis for the nomination, and a statement from the
nominee that indicates that the individual is willing to serve as a
member of the Task Force, if selected; (2) the nominator's name,
address, and daytime telephone number, and the address, telephone
number, and email address of the individual being nominated; and (3) a
current copy of the nominee's curriculum vitae or resume, which should
be limited to no more than 10 pages.
Every effort will be made to ensure that the composition of the
Task Force includes individuals from various geographic locations,
including rural and underserved areas; racial and ethnic minorities;
genders, and persons living with disabilities.
Individuals other than officers or employees of the United States
government being considered for appointment as members of the Task
Force will be required to complete and submit a report of their
financial holdings. An ethics review must be conducted to ensure that
individuals appointed as members of the Task Force are not involved in
any activity that may pose a potential conflict of interest for the
official duties that are to be performed. This is a federal ethics
requirement that must be satisfied upon entering the position and
annually throughout the established term of appointment on the Task
Force.
Authority: Section 101 of the Comprehensive Addiction and Recovery
Act of 2016 (Pub. L. 114-198) authorizes establishment of the Pain
Management Best Practices Inter-Agency Task Force. The Task Force will
be governed by provisions of the Federal Advisory Committee Act, Public
Law 92-463, as amended (5 U.S.C. App. 2), which sets forth standards
for the formation and use of Federal advisory committees.
Dated: August 21, 2017.
Donald Wright,
Acting Assistant Secretary for Health.
[FR Doc. 2017-18182 Filed 8-25-17; 8:45 am]
BILLING CODE 4150-28-P
